JP2006508326A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508326A5
JP2006508326A5 JP2003575071A JP2003575071A JP2006508326A5 JP 2006508326 A5 JP2006508326 A5 JP 2006508326A5 JP 2003575071 A JP2003575071 A JP 2003575071A JP 2003575071 A JP2003575071 A JP 2003575071A JP 2006508326 A5 JP2006508326 A5 JP 2006508326A5
Authority
JP
Japan
Prior art keywords
marker
biomarker
iii
xiv
capture reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003575071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508326A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/006850 external-priority patent/WO2003076896A2/en
Publication of JP2006508326A publication Critical patent/JP2006508326A/ja
Publication of JP2006508326A5 publication Critical patent/JP2006508326A5/ja
Pending legal-status Critical Current

Links

JP2003575071A 2002-03-06 2003-03-06 乳癌を検出するためのバイオマーカーの使用 Pending JP2006508326A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36247302P 2002-03-06 2002-03-06
PCT/US2003/006850 WO2003076896A2 (en) 2002-03-06 2003-03-06 Use of biomarkers to detect breast cancer

Publications (2)

Publication Number Publication Date
JP2006508326A JP2006508326A (ja) 2006-03-09
JP2006508326A5 true JP2006508326A5 (enExample) 2006-04-20

Family

ID=27805178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003575071A Pending JP2006508326A (ja) 2002-03-06 2003-03-06 乳癌を検出するためのバイオマーカーの使用

Country Status (6)

Country Link
US (1) US20050170352A1 (enExample)
EP (1) EP1585962A4 (enExample)
JP (1) JP2006508326A (enExample)
AU (1) AU2003217954A1 (enExample)
CA (1) CA2478036A1 (enExample)
WO (1) WO2003076896A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7951529B2 (en) * 2004-09-17 2011-05-31 The Johns Hopkins University Biomarkers for breast cancer
GB0514555D0 (en) 2005-07-15 2005-08-24 Nonlinear Dynamics Ltd A method of analysing separation patterns
GB0514553D0 (en) 2005-07-15 2005-08-24 Nonlinear Dynamics Ltd A method of analysing a representation of a separation pattern
CA2653398A1 (en) * 2006-05-26 2007-12-06 Board Of Regents, The University Of Texas System Reverse phase protein array, protein activation and expression signatures, and associated methods
US8026108B1 (en) * 2006-10-19 2011-09-27 The University Of Central Florida Research Foundation, Inc. Detection of biotargets using bioreceptor functionalized nanoparticles
JP5219440B2 (ja) * 2007-09-12 2013-06-26 キヤノン株式会社 測定装置
US8710429B2 (en) * 2007-12-21 2014-04-29 The Board Of Regents Of The University Of Ok Identification of biomarkers in biological samples and methods of using same
JP2009236908A (ja) * 2008-03-04 2009-10-15 Kazuhiro Imai 乳癌の診断及び治療法
JP5837761B2 (ja) * 2010-05-12 2015-12-24 イーエヌ大塚製薬株式会社 クローン病の活動性の分類
US8666673B2 (en) * 2010-05-14 2014-03-04 Biomerieux, Inc Identification and/or characterization of a microbial agent using taxonomic hierarchical classification
WO2018069891A2 (en) * 2016-10-13 2018-04-19 University Of Florida Research Foundation, Inc. Method and apparatus for improved determination of node influence in a network
US10380739B2 (en) * 2017-08-15 2019-08-13 International Business Machines Corporation Breast cancer detection
CN110824166A (zh) * 2019-11-20 2020-02-21 淄博市中心医院 一种便捷的肿瘤标志物分子检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
AUPQ886100A0 (en) * 2000-07-19 2000-08-10 Biotron Limited Diagnostic test
US6703204B1 (en) * 2000-07-28 2004-03-09 The Brigham & Women's Hospital, Inc. Prognostic classification of breast cancer through determination of nucleic acid sequence expression

Similar Documents

Publication Publication Date Title
Clark et al. Representation and relative abundance of cell-type selective markers in whole-kidney RNA-Seq data
JP2008533471A5 (enExample)
JP2006508326A5 (enExample)
ES2653646T3 (es) Diagnóstico para cáncer colorrectal
US8354231B2 (en) Methods and systems for detecting and/or sorting targets
HRP20160127T1 (hr) Biomarkeri raka pluä†a i njihove uporabe
JP2009521215A5 (enExample)
JP2012508865A5 (enExample)
JP2009522578A5 (enExample)
JP2009504142A5 (enExample)
BR112012019542A2 (pt) "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit"
CN109661578A (zh) 用于区分细菌和病毒感染的蛋白质特征
KR20100012847A (ko) 생물학적 샘플에서 희귀 사건 분석을 위한 고감도 다중매개변수 방법
CN107209175A (zh) 用于st2心脏生物标志物的测试装置和方法
HRP20130127T1 (hr) Prediktivni biomarkeri bubrežne sigurnosti i potpisi biomarkera za praä†enje funkcije bubrega
JP2012502281A5 (enExample)
JP2017508970A5 (enExample)
JP2013539032A5 (enExample)
UA124522C2 (uk) Спосіб кількісної оцінки рівнів простатичного антигену
KR20180036787A (ko) 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법
JP2007508527A5 (enExample)
Schor et al. Heterogeneity in microvascular density in lung tumours: comparison with normal bronchus
JP2016519767A5 (enExample)
JP2007533985A5 (enExample)
Balci et al. Use of the nuclear matrix protein 22 Bladder Chek test™ in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer